Guided Therapeutics Inc (OTC:GTHP)
| Market Cap | 13.97M-37.1% |
| Revenue (ttm) | 650.00K+450.8% |
| Net Income | -3.73M-46.4% |
| EPS | -0.04+5.0% |
| Shares Out | 96.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Open | 0.14 |
| Previous Close | 0.15 |
| Day's Range | 0.14 - 0.14 |
| 52-Week Range | 0.13 - 0.54 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About GTHP
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Ask Barron about GTHP
$GTHP stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in GTHP holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by GTHP's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
GTHP Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New GTHP patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to GTHP from public contracts
Source: USAspending.gov
GTHP Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from GTHP’s recent data — informational, not investment advice